NCT01201551View on ClinicalTrials.gov

Effect of Alphagan and Xalatan Eye Drops on Corneal Temperature

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

November 30, 2013

Study Completion Date

November 30, 2013

Conditions
Primary Vascular Dysregulation
Interventions
DRUG

Brimonidine

Week1, day2: 1 eyedrop/right eye Week2, day1: 1 eyedrop/left eye Week2, day2: 1 eyedrop/left eye

DRUG

Latanoprost

Week1, day1: 1 eyedrop/right eye Week1, day2: 1 eyedrop/right eye Week2, day2: 1 eyedrop/left eye

DRUG

Placebo

Week1, day1: 1 eyedrop/left eye Week1, day2: 2 eyedrops/left eye Week2, day1: 1 eyedrop/right eye Week2, day2: 2 eyedrops/right eye

Trial Locations (1)

4031

University of Basel, Dept. of Ophthalmology, Basel

All Listed Sponsors
lead

University Hospital, Basel, Switzerland

OTHER

NCT01201551 - Effect of Alphagan and Xalatan Eye Drops on Corneal Temperature | Biotech Hunter | Biotech Hunter